MaturedCor.4U

 

Axiogenesis is happy to announce the addition of a new product to the Cor.4U product family:

A further matured version of our human iPSC-derived cardiomyocytes.

For our new MaturedCor.4U, we have used our expertise and innovative technology to optimize and extend the cardiomyocytes culturing and maturation process.

MaturedCor.4U possess more adult-like properties and represent an ideal tool for specialized applications including manual and automated patch clamp for functional analysis of ion channels in drug safety / toxicology and drug screening.

Watch out for more product news to come up in the next weeks.

Axiogenesis is now looking for beta testers to drive customer-specific characterization of the Matured Cor.4U cells.

Please reach out to This email address is being protected from spambots. You need JavaScript enabled to view it. if you want to apply to participate in our beta testing program.

We expect cells to be shipped in July 2016.  

MaturedCor.4U human iPSC-derived matured cardiomyocytesMaturedCor.4U Immunofluorescence staining of alpha-actinin in MaturedCor.4U (DAPI in blue)  

FIND US

Nattermannallee 1, Bldg S20
50829 Cologne
Germany –  (Map)

600 W Germantown Pike, Suite 110
Plymouth Meeting, PA 19462
USA – (Map)

EMAIL US

Orders: order@axiogenesis.com
Support: support@axiogenesis.com
Other: office@axiogenesis.com

FOLLOW US

Twitter:  |   LinkedIn:  |   Newsletter:  Subscribe Axiogenesis Newsletter

CALL US

Phone (Main)
+49 221 99 88 18-0

Phone (US)
+1 844-511-6959

Fax + 49 221 99 88 18-10